Merck

According to GlobalData’s latest report, there is set to be a smaller proportion of global drug sales which will have patent…

US pharma manufacturing sees investment surge amid tariff shifts, while BRICS nations push regulatory reforms to expand biosimilar…

Suneela Thatte highlighted that while the GCC was initially set up for cost savings in drug development, the focus has shifted to…

Merck faces setback as Keytruda combination trials fail to expand cancer treatment ahead of patent loss

Cladribine capsules have the potential to be the first oral treatment for gMG patients

When compared to patients in the control arm, patients in the vibostolimab and pembrolizumab fixed-dose combination arm…

This is the first pneumococcal vaccine that is specifically designed to protect against serotypes which particularly infect older…

The decision follows a pre-planned interim analysis which found that the trial would be unlikely to meet its primary objective of…

Approval marks the third FDA-approved indication for KEYTRUDA in endometrial carcinoma and the 40th indication for KEYTRUDA in the…

Across four Phase 3 studies, CAPVAXIVE demonstrated robust immune responses in both vaccine-naïve and vaccine-experienced adult…